Clinical efficacy of left ventricular pacing vector programmability in cardiac resynchronization therapy defibrillator patients for management of phrenic nerve stimulation and/or elevated left ventricular pacing thresholds: Insights from the Efface Phrenic Stim study

Europace

Volumn 14, Issue 6, 2012, Pages 826-832

  Klein, Norbert ^a   Klein, Maika ^a   Weglage, Heinrich ^b   Przibille, Oliver ^c   Fischer, Sven ^d   Trappe, Hans Joachim ^e   Birkenhauer, Frank ^f   Pfeiffer, Dietrich ^a  

^a Medizinische Klinik I   (Germany)

^b Niels Stensen Kliniken Marienhospital   (Germany)

^c CARDIOANGIOLOGISCHES CENTRUM BETHANIEN   (Germany)

^d Klinikum Dorothea Christiane Erxleben Quedlinburg gGmbH   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f St Jude Medical GmbH   (Germany)

Author keywords

Cardiac resynchronization therapy; Heart failure; Left ventricular pacing threshold; Phrenic nerve stimulation

Indexed keywords

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BODY POSITION; BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL EFFECTIVENESS; DEFIBRILLATOR; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NERVE STIMULATION; NONISCHEMIC CARDIOMYOPATHY; OBSERVATIONAL STUDY; PHRENIC NERVE; PHRENIC NERVE PACING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINUS NODE DISEASE;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; ELECTRODES, IMPLANTED; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PHRENIC NERVE; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84861630223     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur412     Document Type: Article

References (28)

1. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 2010;12:1526-36.
2. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:391-479.
3. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace 2007;9:959-98.
4. Yu CM, Wing-Hong Fung J, Zhang Q, Sanderson JE. Understanding nonresponders of cardiac resynchronization therapy-current and future perspectives. J Cardiovasc Electrophysiol 2005;16:1117-24.
5. Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40: 111-18.
6. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. J Am Med Assoc 2003; 289:2685-94.
7. Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780-7.
8. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-33.
9. Achtelik M, Bocchiardo M, Trappe HJ, Gaita F, Lozano I, Niazi I, et al. Performance of a new steroid-eluting coronary sinus lead designed for left ventricular pacing. Pacing Clin Electrophysiol 2000;23:1741-3.
10. Abraham WT, Young JB, Leon AR, Adler S, Bank AJ, Hall SA, et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004;110:2864-8.
11. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
12. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
13. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-43.
14. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
15. Knight BP, Desai A, Coman J, Faddis M, Yong P. Long-term retention of cardiac resynchronization therapy. J Am Coll Cardiol 2004;44:72-7.
16. Gurevitz O, Nof E, Carasso S, Luria D, Bar-Lev D, Tanami N. Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation. Pacing Clin Electrophysiol 2005;28: 1255-9.
17. Biffi M, Moschini C, Bertini M, Saporito D, Ziacchi M, Diemberger I, et al. Phrenic stimulation: a challenge for cardiac resynchronization therapy. Circ Arrhythmia Electrophysiol 2009;2:402-10.
18. Seifert M, Schau T, Moeller V, Neuss M, Meyhoefer J, Butter C. Influence of pacing configurations, body mass index, and position of coronary sinus lead on frequency of phrenic nerve stimulation and pacing thresholds under cardiac resynchronization therapy. Europace 2010;12:961-7.
19. Biffi M, Boriani G Phrenic stimulation management in CRT patients: are we there yet? Curr Opin Cardiol 2010 26 12-6
20. Burri H, Gerritse B, Davenport L, Demas M, Sticherling C, et al. Fluctuation of left ventricular thresholds and required safety margin for left ventricular pacing with cardiac resynchronization therapy. Europace 2009;11:931-6.
21. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442.
22. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
23. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
24. Leon AR, Abraham WT, Curtis AB, Daubert JP, Fisher WG, Gurley J, et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol 2005;46:2348-56.
25. Shetty AK, Duckett SG, Bostock J, Roy D, Ginks M, Hamid S, et al. Initial singlecenter experience of a quadripolar pacing lead for cardiac resynchronization therapy. Pacing Clin Electrophysiol 2011;34:484-9.
26. Forleo GB, Della Rocca DG, Papavasileiou LP, Molfetta AD, Santini L, Romeo F. Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcomes. Heart Rhythm 2011;8:31-7.
27. Champagne J, Healey JS, Krahn AD, Philippon F, Gurevitz O, Swearingen A, et al. The effect of electronic repositioning on left ventricular pacing and phrenic nerve stimulation. Europace 2011;13:409-15.
28. Burger H, Schwarz T, EhrlichW, Sperzel J, Kloevekorn WP, Ziegelhoeffer T. New generation of transvenous left ventricular leads-first experience with implantation of multipolar left ventricular leads. Exp Clin Cardiol 2011;16:23-6.